These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 15788149
1. Pimecrolimus--a safe and effective local immunomodulator in the treatment of inflammatory skin diseases. Lipozencić J. Acta Dermatovenerol Croat; 2005; 13(1):63-9. PubMed ID: 15788149 [Abstract] [Full Text] [Related]
3. Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases. Hebert AA, Warken KA, Cherill R. Semin Cutan Med Surg; 2001 Dec; 20(4):260-7. PubMed ID: 11770913 [Abstract] [Full Text] [Related]
4. Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity. Stuetz A, Grassberger M, Meingassner JG. Semin Cutan Med Surg; 2001 Dec; 20(4):233-41. PubMed ID: 11770910 [Abstract] [Full Text] [Related]
5. Pimecrolimus -- an anti-inflammatory drug targeting the skin. Grassberger M, Steinhoff M, Schneider D, Luger TA. Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755 [Abstract] [Full Text] [Related]
6. Pimecrolimus in dermatology: atopic dermatitis and beyond. Gisondi P, Ellis CN, Girolomoni G. Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622 [Abstract] [Full Text] [Related]
7. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus. Stuetz A, Baumann K, Grassberger M, Wolff K, Meingassner JG. Int Arch Allergy Immunol; 2006 Aug; 141(3):199-212. PubMed ID: 16926539 [Abstract] [Full Text] [Related]
9. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases. Bornhövd EC, Burgdorf WH, Wollenberg A. Curr Opin Investig Drugs; 2002 May; 3(5):708-12. PubMed ID: 12090543 [Abstract] [Full Text] [Related]
10. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. Bornhövd E, Burgdorf WH, Wollenberg A. J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925 [Abstract] [Full Text] [Related]
11. Pimecrolimus in dermatology. Fabroni C, Lotti T. G Ital Dermatol Venereol; 2009 Jun; 144(3):321-5. PubMed ID: 19528913 [Abstract] [Full Text] [Related]
12. Ascomycins in dermatology. Paul C, Ho VC. Semin Cutan Med Surg; 1998 Dec; 17(4):256-9. PubMed ID: 9859912 [Abstract] [Full Text] [Related]
13. Pimecrolimus: a review of pre-clinical and clinical data. Graham-Brown RA, Grassberger M. Int J Clin Pract; 2003 May; 57(4):319-27. PubMed ID: 12800465 [Abstract] [Full Text] [Related]
14. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis]. de Bruin-Weller MS, Bruijnzeel-Koomen CA. Ned Tijdschr Geneeskd; 2005 May 14; 149(20):1096-100. PubMed ID: 15932135 [Abstract] [Full Text] [Related]
15. Pimecrolimus for the treatment of inflammatory skin disease. Wolff K, Stuetz A. Expert Opin Pharmacother; 2004 Mar 14; 5(3):643-55. PubMed ID: 15013932 [Abstract] [Full Text] [Related]
16. Topical tacrolimus and pimecrolimus: future directions. Ling MR. Semin Cutan Med Surg; 2001 Dec 14; 20(4):268-74. PubMed ID: 11770914 [Abstract] [Full Text] [Related]
17. Pimecrolimus 1% cream for the treatment of atopic dermatitis. Wolff K. Skin Therapy Lett; 2005 Oct 14; 10(8):1-6. PubMed ID: 16292456 [Abstract] [Full Text] [Related]
18. Topical pimecrolimus for skin disease other than atopic dermatitis. Wollina U, Hansel G, Koch A, Abdel-Naser MB. Expert Opin Pharmacother; 2006 Oct 14; 7(14):1967-75. PubMed ID: 17020422 [Abstract] [Full Text] [Related]
19. Pimecrolimus, yet another intriguing topical immunomodulator. Sehgal VN, Pahwa M. J Dermatolog Treat; 2007 Oct 14; 18(3):147-50. PubMed ID: 17538802 [Abstract] [Full Text] [Related]
20. [Tacrolimus and pimecrolimus ointments in the treatment of atopic eczema]. Reitamo S, Remitz A. Duodecim; 2003 Oct 14; 119(9):825-7. PubMed ID: 12815980 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]